SAN CARLOS, Calif., Jan. 5 Nektar Therapeutics'(Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, isscheduled to present at the upcoming 27th Annual J.P. Morgan HealthcareConference in San Francisco at the Westin St. Francis Hotel on Tuesday,January 13, 2009 at 10:00 a.m. Pacific time (1:00 p.m. Eastern time).
The presentation will be accessible via a Webcast through a link posted onthe Investor Relations, Events Calendar section of the Nektar website:http://www.nektar.com. This Webcast will be available for replay untilFebruary 15, 2009.
Nektar Therapeutics is a biopharmaceutical company developing noveltherapeutics based on its advanced polymer conjugate technology platforms.Nektar's technology and drug development expertise have enabled nine approvedproducts for partners, which include leading biopharmaceutical companies.Nektar is also developing a robust pipeline of its own high-value therapeuticsthat addresses unmet medical needs by leveraging and expanding its technologyplatforms to improve and enable molecules. For more information on NektarTherapeutics, please visit http://www.nektar.com.Nektar Contacts: Jennifer Ruddock Nektar Therapeutics 650-631-4954 firstname.lastname@example.org Susan Noonan The SAN Group 212-966-3650 email@example.com
SOURCE Nektar Therapeutics